<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091597</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00008424</org_study_id>
    <nct_id>NCT01091597</nct_id>
  </id_info>
  <brief_title>Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation</brief_title>
  <official_title>PV Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Curative catheter ablation has been established as an effective therapeutic option for atrial
      fibrillation (AF) that is resistant to pharmacologic rhythm or rate control. However,
      standard ablative approaches targeting the pulmonary veins (PVs) are associated with a
      success rate as low as 40%. In a recent study, Kumagai et al. described a new approach of
      catheter ablation of AF isolating the posterior left atrium including all PVs (called Box
      Isolation). In Kumagai's study, 46 patients with symptomatic AF underwent box isolation. At 6
      months follow up, 43 of 46 patients (93%) were arrhythmia free without antiarrhythmic drugs,
      with a single procedure success rate of 87% (40/46). This study provided new evidence
      supporting the hypothesis that the posterior wall is of high importance for the maintenance
      of AF. The aim of the investigators study is to determine the efficacy of two different
      approaches of catheter ablation (Standard PV Isolation vs. Box isolation) for the treatment
      of chronic AF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>freedom from atrial fibrillation</measure>
    <time_frame>3 months following ablation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>safety of Box isolation</measure>
    <time_frame>3 months following procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Radiofrequency Ablation</condition>
  <arm_group>
    <arm_group_label>usual ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wide-area circumferential ablation of the pulmonary veins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Box isolation of the pulmonary veins</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single Box lesion set encompassing all four pulmonary veins and the posterior wall of the left atrium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>usual PV ablation</intervention_name>
    <description>usual PV ablation, per above</description>
    <arm_group_label>usual ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Box isolation of pulmonary veins</intervention_name>
    <description>as above</description>
    <arm_group_label>Box isolation of the pulmonary veins</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing clinically indicated pulmonary vein ablation for atrial
             fibrillation.

        Exclusion Criteria:

          -  Unable to understand consent form. Not scheduled for clinically indicated pulmonary
             vein ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>March 23, 2010</last_update_submitted>
  <last_update_submitted_qc>March 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Charles Henrikson, MD</name_title>
    <organization>Johns Hopkins University</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

